Found: 2
Select item for more details and to access through your institution.
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1001, doi. 10.1007/s10637-022-01277-9
- By:
- Publication type:
- Article
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 2, p. 315, doi. 10.1007/s40257-022-00741-9
- By:
- Publication type:
- Article